| IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 ID Mascanfroni, A Yeste, SM Vieira, EJ Burns, B Patel, I Sloma, Y Wu, ... Nature immunology 14 (10), 1054-1063, 2013 | 396 | 2013 |
| Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors E Izumchenko, K Paz, D Ciznadija, I Sloma, A Katz, D Vasquez-Dunddel, ... Annals of Oncology 28 (10), 2595-2605, 2017 | 323 | 2017 |
| Cholesterol pathway inhibition induces TGF-β signaling to promote basal differentiation in pancreatic cancer L Gabitova-Cornell, A Surumbayeva, S Peri, J Franco-Barraza, D Restifo, ... Cancer cell 38 (4), 567-583. e11, 2020 | 153 | 2020 |
| Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related … F Erhart, J Buchroithner, R Reitermaier, K Fischhuber, S Klingenbrunner, ... Acta neuropathologica communications 6, 1-14, 2018 | 54 | 2018 |
| In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia E Makarev, AD Schubert, RR Kanherkar, N London, M Teka, I Ozerov, ... Cell death discovery 3 (1), 1-7, 2017 | 36 | 2017 |
| Volasertib preclinical activity in high-risk hepatoblastoma D Kats, CA Ricker, NE Berlow, B Noblet, D Nicolle, K Mevel, ... Oncotarget 10 (60), 6403, 2019 | 23 | 2019 |
| AL101 mediated tumor inhibition in notch-altered TNBC PDX models. EC Broner, G Alpert, U Gluschnaider, A Mondshine, O Solomon, I Sloma, ... Journal of Clinical Oncology 37 (15_suppl), 1064-1064, 2019 | 16 | 2019 |
| Comparative mutational landscape analysis of patient-derived tumour xenografts M Brait, E Izumchenko, LT Kagohara, S Long, PT Wysocki, B Faherty, ... British journal of cancer 116 (4), 515-523, 2017 | 12 | 2017 |
| Interleukin-27 acts on dendritic cells to suppress the T-cell response and autoimmunity by inducing the expression of ENTPD1 (CD39) ID Mascanfroni, A Yeste, SM Vieira, EJ Burns, B Patel, I Sloma, Y Wu, ... Nature immunology 14 (10), 1054, 2013 | 11 | 2013 |
| Alternative splicing of RAD6B and not RAD6A is selectively increased in melanoma: identification and functional characterization A Gajan, CE Martin, S Kim, M Joshi, SK Michelhaugh, I Sloma, S Mittal, ... Cells 8 (11), 1375, 2019 | 9 | 2019 |
| Pharmaco-Pheno-Multiomic integration reveals biomarker profiles and therapeutic response prediction models in leukemia and ovarian cancer G Silberberg, B Walling, A Wesa, A Audia, I Sloma, Y Zeng, G Han, J Tang, ... bioRxiv, 2022.06. 14.495846, 2022 | 2 | 2022 |
| Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists V Grinkevitch, M Wappett, N Crawford, S Price, A Lees, C McCann, ... Molecular cancer therapeutics 21 (4), 594-606, 2022 | 2 | 2022 |
| A tyrosine kinase protein interaction map reveals targetable EGFR network oncogenesis in lung cancer S Kaushik, F Haderk, X Zhao, HM Hu, KN Shah, GM Jang, V Olivas, ... bioRxiv, 2020.07. 02.185173, 2020 | 2 | 2020 |
| Validation of qBiomarker as an accurate and efficient mutation detection method in a comprehensive analysis of patient-derived tumor xenografts M Brait, E Izumchenko, L Kagohara, S Long, P Wysocki, B Faherty, ... Cancer Research 76 (14_Supplement), 3640-3640, 2016 | 2 | 2016 |
| Abstract P174: YAP1 drives immune suppression in urothelial carcinoma of bladder P Sadhukhan, M Feng, E Illingworth, I Sloma, MT Ugurlu, F Sille, W Choi, ... Molecular Cancer Therapeutics 20 (12_Supplement), P174-P174, 2021 | 1 | 2021 |
| Doublecortin-like kinase 1 (DCLK1) is novel Notch pathway signaling regulator in HNSCC EC Broner, T Subbannayya, A Zhavoronkov, M Korzinkin, A Artemov, ... Cancer Research 79 (13_Supplement), 3443-3443, 2019 | 1 | 2019 |
| Experimental support for the ecoimmunity theory: distinct phenotypes of nonlymphocytic cells in SCID and wild-type mice DE Ochayon, BM Baranovski, P Malkin, R Schuster, N Kalay, ... Cell Transplantation 25 (8), 1575-1588, 2016 | 1 | 2016 |
| A patient-centric repository of PDX models for translational oncology research TO Khor, I Ben Zvi, A Katz, D Vasquez-Dunddel, I Sloma, D Ciznadija, ... Cancer research 75 (15_Supplement), 3219-3219, 2015 | 1 | 2015 |
| YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulation P Sadhukhan, M Feng, E Illingworth, I Sloma, A Ooki, A Matoso, ... The Journal of Clinical Investigation 135 (2), 2025 | | 2025 |
| Saliva TCR repertoire as a tool for head and neck cancer immunophenotype monitoring DG De Lima, M Brait, L Palmieri, FT Zamuner, E Broner, KN Smith, ... Cancer Research 83 (7_Supplement), 2121-2121, 2023 | | 2023 |
